Dr. Wang brings over 20 years of experience and skills in the drug safety assessment area, not only in science and technologies, also in leading a GLP compliant safety assessment facility.
汪博士从事药物安全性评价工作超过20年，在药物安全性评价领域及机构的GLP法规遵循管理方面积累了非常丰富的经验。
Assessment of drug safety is the necessary part in the course of development of new drugs.
药物安全评价是新药开发过程中不可缺少的部分。
In recent years, the great development of toxicokinetics and toxicogenomics solved many problems in animal experiments, and consummated the system of assessment of drug safety.
近年来，毒代动力学以及毒理基因组学的飞速发展，解决了传统动物毒性实验中所面临的很多问题，逐步完善了药物安全评价体系。
AIM: to apply negative binomial model for the safety assessment of a new drug, so as to analyze the occurrence of adverse events.
目的：将负二项回归用于新药的安全性评价，以此分析评价不良事件的发生情况。
AIM: to apply negative binomial model for the safety assessment of a new drug, so as to analyze the occurrence of adverse events.
目的：将负二项回归用于新药的安全性评价，以此分析评价不良事件的发生情况。
应用推荐